These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 30511789)
1. Interventions to promote adherence to endocrine therapy among breast cancer survivors: A meta-analysis. Finitsis DJ; Vose BA; Mahalak JG; Salner AL Psychooncology; 2019 Feb; 28(2):255-263. PubMed ID: 30511789 [TBL] [Abstract][Full Text] [Related]
2. Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data. Sheppard VB; He J; Sutton A; Cromwell L; Adunlin G; Salgado TM; Tolsma D; Trout M; Robinson BE; Edmonds MC; Bosworth HB; Tadesse MG J Manag Care Spec Pharm; 2019 May; 25(5):578-586. PubMed ID: 31039059 [TBL] [Abstract][Full Text] [Related]
3. Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence? Ekinci E; Nathoo S; Korattyil T; Vadhariya A; Zaghloul HA; Niravath PA; Abughosh SM; Trivedi MV J Cancer Surviv; 2018 Jun; 12(3):348-356. PubMed ID: 29396760 [TBL] [Abstract][Full Text] [Related]
4. A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors. Bright EE; Finkelstein LB; Nealis MS; Genung SR; Wrigley J; Gu HCJ; Schmiege SJ; Arch JJ J Clin Oncol; 2023 Oct; 41(28):4548-4561. PubMed ID: 37531593 [TBL] [Abstract][Full Text] [Related]
5. Exploring the role of social support and adjuvant endocrine therapy use among breast cancer survivors. Toledo G; Ochoa CY; Farias AJ Support Care Cancer; 2020 Jan; 28(1):271-278. PubMed ID: 31037379 [TBL] [Abstract][Full Text] [Related]
6. Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study. Bluethmann SM; Murphy CC; Tiro JA; Mollica MA; Vernon SW; Bartholomew LK Oncol Nurs Forum; 2017 May; 44(3):E101-E110. PubMed ID: 28635973 [TBL] [Abstract][Full Text] [Related]
7. Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Kroenke CH; Hershman DL; Gomez SL; Adams SR; Eldridge EH; Kwan ML; Ergas IJ; Kubo A; Kushi LH Breast Cancer Res Treat; 2018 Aug; 170(3):623-631. PubMed ID: 29671113 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer patients' experiences of adherence and persistence to oral endocrine therapy: A qualitative evidence synthesis. Clancy C; Lynch J; OConnor P; Dowling M Eur J Oncol Nurs; 2020 Feb; 44():101706. PubMed ID: 32007696 [TBL] [Abstract][Full Text] [Related]
9. Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review. Lambert LK; Balneaves LG; Howard AF; Gotay CC Breast Cancer Res Treat; 2018 Feb; 167(3):615-633. PubMed ID: 29110151 [TBL] [Abstract][Full Text] [Related]
10. Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data. Lailler G; Memoli V; Le Bihan Benjamin C; Ben Diane MK; Lauzier S; Mancini J; Bousquet PJ; Bouhnik AD Clin Breast Cancer; 2021 Aug; 21(4):e415-e426. PubMed ID: 33745868 [TBL] [Abstract][Full Text] [Related]
11. Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution. Hwang GS; Paranjpe R; Opsomer C; Lu K; Abajue U; Abughosh S; Zaghloul H; Trivedi MV Clin Breast Cancer; 2020 Dec; 20(6):520-526. PubMed ID: 32669209 [TBL] [Abstract][Full Text] [Related]
12. Applying the theory of planned behavior to examine adjuvant endocrine therapy adherence intentions. Hurtado-de-Mendoza A; Carrera P; Parrott WG; Gómez-Trillos S; Perera RA; Sheppard VB Psychooncology; 2019 Jan; 28(1):187-194. PubMed ID: 30353610 [TBL] [Abstract][Full Text] [Related]
13. Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer. Lee JY; Min YH BMC Womens Health; 2018 Mar; 18(1):48. PubMed ID: 29551094 [TBL] [Abstract][Full Text] [Related]
14. Depression as a predictor of adherence to adjuvant endocrine therapy (AET) in women with breast cancer: a systematic review and meta-analysis. Mausbach BT; Schwab RB; Irwin SA Breast Cancer Res Treat; 2015 Jul; 152(2):239-46. PubMed ID: 26077640 [TBL] [Abstract][Full Text] [Related]
15. Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients. Jacob Arriola KR; Mason TA; Bannon KA; Holmes C; Powell CL; Horne K; O'Regan R Patient Educ Couns; 2014 Apr; 95(1):98-103. PubMed ID: 24492157 [TBL] [Abstract][Full Text] [Related]
16. Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management. Cavazza M; Banks H; Ercolanoni M; Cukaj G; Bianchi G; Capri G; Longo F Breast Cancer Res Treat; 2020 Aug; 183(1):189-199. PubMed ID: 32591986 [TBL] [Abstract][Full Text] [Related]
17. Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women. Kuba S; Maeda S; Matsumoto M; Yamanouchi K; Yano H; Morita M; Sakimura C; Hatachi T; Tokai Y; Takatsuki M; Fujioka H; Hayashida N; Nagayasu T; Eguchi S Clin Breast Cancer; 2018 Apr; 18(2):150-156. PubMed ID: 29290564 [TBL] [Abstract][Full Text] [Related]
18. Systematic adaptation of the adherence improving self-management strategy to support breast cancer survivors' adherence to adjuvant endocrine therapy: An intervention mapping approach. Janssen AM; Dam J; Prins J; Buffart LM; de Bruin M Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13721. PubMed ID: 36263723 [TBL] [Abstract][Full Text] [Related]
19. Remote Monitoring App for Endocrine Therapy Adherence Among Patients With Early-Stage Breast Cancer: A Randomized Clinical Trial. Graetz I; Hu X; Kocak M; Krukowski RA; Anderson JN; Waters TM; Curry AN; Robles A; Paladino A; Stepanski E; Vidal GA; Schwartzberg LS JAMA Netw Open; 2024 Jun; 7(6):e2417873. PubMed ID: 38935379 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States. Daly B; Olopade OI; Hou N; Yao K; Winchester DJ; Huo D JAMA Oncol; 2017 Jul; 3(7):928-935. PubMed ID: 28152150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]